August 27, 2014 11:29 PM ET

Healthcare Providers and Services

Company Overview of AbilTo LLC

Executive Profile

Shari I. Lusskin M.D.

Member of Board of Advisor, AbilTo LLC
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Shari I. Lusskin, M.D., serves as Director of Psychopharmacologic Agents for the Reproductive Toxicology Center. Dr. Lusskin also serves as Clinical Associate Professor of Psychiatry, Obstetrics, and Gynecology at New York University School of Medicine / NYU Langone Medical Center, where she founded the Reproductive Psychiatry Program. She also serves as an Adjunct Associate Professor at The Mount Sinai School of Medicine. She has been a Member of Board of Advisors ...

Corporate Headquarters

954 Lexington Avenue
New York, New York 10021

United States

Phone: 646-558-3245
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AbilTo LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.